Review of statistical methods for analysing healthcare resources and costs. by Mihaylova, B, Briggs, A, O'Hagan, A, Thompson, S

Inverse probability weighted least squares regression in the analysis of time-censored cost data: an evaluation of the approach using SEER-Medicare. by Griffiths, R, Gleeson, M, Danese, MD, O'Hagan, A

Anti-inflammatory dosing of theophylline in the treatment of status asthmaticus in children by Eid N, O'Hagan A, Bickel S, Morton R, Jacobson S, Myers J

Get full text

Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer. by Griffiths, R, Barron, R, Gleeson, M, Danese, MD, O'Hagan, A, Chia, V, Legg, J, Lyman, G

The Multiple Sclerosis Risk Sharing Scheme Monitoring Study – early results and lessons for the future by Pickin, M, Cooper, C, Chater, T, O'Hagan, A, Abrams, K, Cooper, N, Boggild, M, Palace, J, Ebers, G, Chilcott, J, Tappenden, P, Nicholl, J

The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the future. by Pickin, M, Cooper, C, Chater, T, O'Hagan, A, Abrams, K, Cooper, N, Boggild, M, Palace, J, Ebers, G, Chilcott, J, Tappenden, P, Nicholl, J

The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review. by Connock, M, Burls, A, Frew, E, Fry-Smith, A, Juarez-Garcia, A, McCabe, C, Wailoo, A, Abrams, K, Cooper, N, Sutton, A, O'Hagan, A, Moore, D

The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review. by Connock, M, Burls, A, Frew, E, Fry-Smith, A, Juarez-Garcia, A, McCabe, C, Wailoo, A, Abrams, K, Cooper, N, Sutton, A, O'Hagan, A, Moore, D

The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review by Connock, M, Burls, A, Frew, E, Fry-Smith, A, Juarez-Garcia, A, McCabe, C, Wailoo, A, Abrams, K, Cooper, N, Sutton, A, O'Hagan, A, Moore, D